Abstract:Synthetic biology is propelling medicine into a new era through its capacity to genetically program living cells. One of the particular interests is engineering bacteria as a live and targeted therapeutic delivery system. Herein, the bacterial biohybrid (E. coli-pE@PCN) is developed by genetically engineering Escherichia coli BL21 to overexpress catalase (E. coli-pE) and electrostatically adsorbing nano-sonosensitizers (PCN NPs) for enhanced and targeted sonodynamic therapy (SDT). Leveraging the ability to colonize and penetrate deep in tumors, engineered bacteria can not only sustainably express catalase to relieve tumor hypoxia, but also facilitate the enriched and expanded distribution of the carried sonosensitizer at the tumor site, so as to trigger effective SDT. More interestingly, it is found that E. coli-pE@PCN-based SDT can successfully inhibit the growth of subcutaneous and orthotopic colorectal tumors by inducing potent antitumor immune responses due to the released tumor-associated antigens and native immunogenicity of bacterial pathogen-associated molecular patterns. Furthermore, E. coli-pE@PCN-based SDT can not only prime a strong immune memory response to prevent tumor recurrence but also elicit a potent abscopal effect to inhibit tumor metastasis. Therefore, the programmable bacteria-based biohybrids developed here pave an avenue to prepare next-generation sonodynamic-immunotherapeutics to eliminate cancer and prevent its relapse and metastasis. A pioneering living biotherapeutic is developed by electrostatically attaching nano-sonosensitizers to engineered bacteria, paving the way for a synergistic sonodynamic-immunotherapy. This innovative method harnesses the power of sonodynamic therapy to facilitate the release of tumor-associated antigens and bacterial pathogen-associated molecular patterns, thereby eliciting robust anti-tumor immune responses to combat cancer progression, metastasis, and recurrence. image

Ultrasound-activated bacteria with thermostat controls as living therapeutics

Programming Living Sensors for Environment, Health and Biomanufacturing

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Programmable Bacteria‐Based Biohybrids As Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Engineered Bacteria-Based Living Materials for Biotherapeutic Applications

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Precise Thermal Regulation of Engineered Bacteria Secretion for Breast Cancer Treatment In Vivo

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy

Engineered Live Biotherapeutics: Progress and Challenges

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.

Programming the lifestyles of engineered bacteria for cancer therapy

In-vivo programmable acoustic manipulation of genetically engineered bacteria

Engineering living therapeutics with synthetic biology

Theranostic cells: emerging clinical applications of synthetic biology

Engineering bacterial theranostics: from logic gates to in vivo applications

Engineering Diagnostic and Therapeutic Gut Bacteria

Engineering bacteria for cancer immunotherapy

Engineering bacterial warriors: harnessing microbes to modulate animal physiology

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity